Skip to main content

Advertisement

Log in

Focal segmental glomerulosclerosis associated with cutaneous and systemic plasmacytosis

  • Case Report
  • Published:
CEN Case Reports Aims and scope Submit manuscript

Abstract

Cutaneous and systemic plasmacytosis (CSP) is a rare lymphoproliferative disorder that mainly affects middle-aged Asian individuals. Although Castleman disease is often complicated with various renal involvements, glomerulonephritis associated with CSP, which is considered as a variant of Castleman disease, is rare. This report presents the case of a 41-year-old Japanese man with nephrotic syndrome associated with CSP. Renal biopsy findings showed focal segmental glomerulosclerosis (FSGS) and diffusely mild segmental mesangial proliferation. Plasma cell infiltration in the interstitium was not observed. Electron microscopic findings showed diffuse foot process effacement, localized involvement of subendothelial space widening with amorphous materials, and endothelial cell swelling. Lymph node biopsy findings denied Castleman disease. His skin regions and proteinuria were successfully treated with prednisolone and cyclosporine. The causal relationship between CSP and FSGS is unknown. However, increased serum levels of IL-6 and VEGF and decreased VEGF expression in the podocyte may contribute to renal lesions in patients with CSP. To our best knowledge, this is the first case of a patient with FSGS associated with CSP.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Yashiro A. A kind of plasmacytosis: primary cutaneous plasmacyoma? Jpn J Dermatol. 1987;86:910.

    Google Scholar 

  2. Watanabe S, Ohara K, Kukita A, et al. Systemic plasmacytosis. A syndrome of peculiar multiple skin eruption, generated lymphadenopathy, and polyclonal hypergammaglobulinemia. Arch Dermatol. 1986;122:1314–20.

    Article  CAS  Google Scholar 

  3. Haque M, Hou JS, Hisamichi K, et al. Cutaneous and systemic plasmacytosis vs. cutaneous plasmacytic Castleman disease: review and speculations about pathogenesis. Clin Lymphoma Myeloma Leuk. 2011;11:453–61.

    Article  Google Scholar 

  4. Kayasut K, Le Tourneau A, Rio B, et al. Are multicentric Castleman’s disease with cutaneous plasmacytosis and systemic plasmacytosis the same entity? Histopathology. 2006;49:557–8.

    Article  CAS  Google Scholar 

  5. El Karoui K, Vuiblet V, Dion D, et al. Renal involvement in Castleman disease. Nephrol Dial Transplant. 2011;26:599–609.

    Article  Google Scholar 

  6. Xu D, Lv J, Dong Y, et al. Renal involvement in a large cohort of Chinese patients with Castleman disease. Nephrol Dial Transplant. 2012;27(Supple 3):iii119–25.

    Article  Google Scholar 

  7. Toda Y, Komine M, Suzuki S, et al. Plasmacytosis: systemic or cutaneous, are they distinct? Acta Dermato Venereol. 2000;80:233–5.

    Google Scholar 

  8. Kodama A, Tani M, Hori K, et al. Systemic and cutaneous plasmacytosis with multiple skin lesion and polyclonal hypergammaglobulinaemia: significant serum interleukin-6 levels. Br J Dermatol. 1992;127:49–53.

    Article  CAS  Google Scholar 

  9. Fogo AB. Causes and pathogenesis of focal segmental glomerulosclerosis. Nat Rev Nephrol. 2015;11:76–87.

    Article  CAS  Google Scholar 

  10. Dingli D, Larson DR, Plevak MF, et al. Focal and segmental glomerulosclerosis and plasma cell proliferative disorder. Am J Kidney Dis. 2005;46:278–82.

    Article  Google Scholar 

  11. Bower M, Stebbing J. Exploring interleukin 6 in multicentric Castleman’s disease. Lancet Oncol. 2014;15:910–2.

    Article  Google Scholar 

  12. Higashi Y, Kanekura T, Sakamoto R, et al. Multicentriic Castleman disease with cutaneous manifestations: report of 2 cases and comparison with systemic plasmacytosis. Dermatology. 2007;214:170–3.

    Article  Google Scholar 

  13. Yuan XG, Hu W, Chen FF, et al. Renal complications of Castleman’s disease: report of two cases and analysis of 75 cases. Clin Exp Nephrol. 2011;15:921–6.

    Article  Google Scholar 

  14. Brandt SJ, Bodine DM, Dunbar CE, et al. Dysregulation interleukin 6 expression produces a syndrome resembling Castleman’s disease in mice. J Clin Invest. 1990;86:592–9.

    Article  CAS  Google Scholar 

  15. Chen WP, Chen A, Lin CY. In vitro effects of interleukins on human mesangial cells: implications for glomerulonephritis. J Pathol. 1995;175:327–37.

    Article  CAS  Google Scholar 

  16. Henao DE, Saleem MA, Cadavid AP. Glomerular disturbances in preeclampsia: disruption between glomerular endothelium and podocyte symbiosis. Hypertens Pregnancy. 2010;29:10–20.

    Article  CAS  Google Scholar 

  17. Wang L, Bu D, Yang Y, et al. Castleman’s tumors and production of autoantibody in paraneoplastic pemphigus. Lancet. 2004;363:525–31.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shinsuke Isobe.

Ethics declarations

Sources of funding

None.

Conflict of interest

All the authors have declared no competing interest.

Human rights

This article does not contain any studies with human participants performed by any of the authors.

Informed consent

Written informed consent was obtained from the patient.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Isobe, S., Ohashi, N., Katahashi, N. et al. Focal segmental glomerulosclerosis associated with cutaneous and systemic plasmacytosis. CEN Case Rep 6, 206–209 (2017). https://doi.org/10.1007/s13730-017-0276-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13730-017-0276-z

Keywords

Navigation